about
Neurodegeneration in multiple sclerosis: novel treatment strategiesA Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesAstrocytes in multiple sclerosis: a product of their environmentIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesAxon growth inhibition by RhoA/ROCK in the central nervous system.Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.Therapeutic Advances and Future Prospects in Progressive Forms of Multiple SclerosisStatin use and cancer risk: an epidemiologic review.Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury.The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.The ROCK/GGTase Pathway Are Essential to the Proliferation and Differentiation of Neural Stem Cells Mediated by Simvastatin.Simvastatin interferes with process outgrowth and branching of oligodendrocytes.Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation.Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy.
P2860
Q22241472-D902EB23-558D-4F16-9266-71788EB13BBBQ28068709-19CAA748-6D6E-484D-A349-AE573A2565A9Q28282324-415FBCF2-EC98-40EF-8E4A-E821DE438F9DQ28388335-B5AFD996-7243-4326-AED3-1396CE2F5BA4Q34384966-12D31994-9E36-4088-8FAF-3C27F60C3FFBQ36228304-7BD4C786-FFDE-4515-BC82-DB824A5CEBC6Q36484443-DCDFFC9F-3DD5-4741-AA41-C66E19CF6D13Q36508082-D261FC71-6C34-4D1B-9CD0-E6AE94475ED6Q36817063-9B17CE05-3D0B-41A8-BD0E-D3077ABAAE0EQ37167232-2CED242A-981C-48A8-95A5-D909C503577EQ37358933-75987787-A009-4869-B4E0-9470E52E8318Q39348762-197839F4-AADC-4A18-9842-A6C3319ECEBBQ39474072-97A8E897-0B01-4951-8B67-512802D5EC0CQ39653271-B45191D6-267E-419C-8291-7ED093B3EC57Q40567163-C0D34F41-3A25-4AE4-BCB8-7CA2A0EAB9B2Q42148986-8ADE270C-103B-4BB4-8A96-2A13EFCC0DBFQ47280518-4673FD33-C587-4E21-81A5-BB74CD1BBAA6Q48293570-CAC388C8-E1B7-4391-87A5-5A00609FC117Q48896378-739A3977-3A41-4642-AA98-65C7DF27F33FQ49090389-41F6ECF2-6029-40F0-A2DF-ADFA046C2F9B
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Are statins a treatment option for multiple sclerosis?
@ast
Are statins a treatment option for multiple sclerosis?
@en
type
label
Are statins a treatment option for multiple sclerosis?
@ast
Are statins a treatment option for multiple sclerosis?
@en
prefLabel
Are statins a treatment option for multiple sclerosis?
@ast
Are statins a treatment option for multiple sclerosis?
@en
P1433
P1476
Are statins a treatment option for multiple sclerosis?
@en
P2093
Oliver Neuhaus
Scott S Zamvil
P304
P356
10.1016/S1474-4422(04)00770-7
P577
2004-06-01T00:00:00Z